The top-notch speaking faculty includes government perspectives from the Department of Veterans Affairs (VA), Department of Defense (DoD), U.S. Public Health Service (PHS) and 340B Prime Vendor Program, and industry perspectives from Amneal, Boehringer Ingelheim, Cornerstone Therapeutics, Horizon Pharma, Johnson and Johnson, Lilly, Pfizer, and Teva. Read more in the official description below or visit the event website.
CBI is offering a special $300 discount to Drug Channels readers. Just register with promo code VADDC3. Thanks, CBI!
OFFICIAL DESCRIPTION FROM CBI
The responsibility to provide lower cost drugs to the "Big Four" federal programs is a crucial endeavor that is lucrative, yet challenging to manage. CBI's 4th Annual VA*DoD*PHS — Federal Pricing and Contracts Forum, taking place on November 28-29, 2012 in Philadelphia, PA, provides proven strategies to comply in the federal arena amidst reform and a shifting political climate.
Join your industry colleagues to discuss:
- HRSA’s Recertification of Entities
- Section 863 and Its Affect on the Federal Supply Schedule
- Managing TRICARE Rebate Process Updates
- Advanced Contracting and Pricing Strategies
- Minimizing the Loss of Profitability
You will benefit from attending this event if you are a senior-level executive at a pharmaceutical or biotech company with responsibilities or involvement in the Pricing, Contracting, Compliance, Reporting, Government Affairs, National Accounts, Business Development & Strategy, Medicaid and Medicare.
This conference will also benefit consultant, technology providers and law firms who supply the industry with assistance in regulatory, compliance and legal challenges regarding product pricing.